BMC Infectious Diseases invites submissions for a Collection on Infectious diseases in infants and children.

Infectious diseases in infants and children represent a significant burden on healthcare systems globally, often leading to serious complications, long-term health issues, and even mortality. This Collection aims to explore the diverse range of infectious diseases that specifically affect the pediatric population, including but not limited to respiratory infections, gastrointestinal infections, and vaccine-preventable diseases. Understanding the unique immune responses and vulnerabilities of young children is crucial for developing effective prevention and treatment strategies tailored to their needs.

The continued research into pediatric infectious diseases is vital for several reasons. Advances in immunization have significantly reduced the incidence of many vaccine-preventable diseases; however, challenges remain, particularly with the emergence of antimicrobial resistance and the resurgence of certain infections. Furthermore, the COVID-19 pandemic has underscored the importance of infection control measures in childcare, preschool, and school settings and highlighted the need for ongoing surveillance of childhood diseases. This area of research promises to contribute to improved health outcomes for infants and children worldwide.

With sustained research efforts, we can anticipate significant advances in the future, including the development of novel vaccines, improved diagnostics, and tailored treatment protocols. Continued exploration of the epidemiology of childhood diseases will further enhance our understanding of transmission dynamics and inform public health interventions.

We invite pediatricians, infectious disease specialists, public health professionals, immunologists, epidemiologists, and researchers in related fields to contribute original research articles on topics including but not limited to:

- Pediatric infectious diseases and their management

- Early childhood immunity and its implications

- Epidemiology of respiratory infections in children

- Antimicrobial resistance trends in pediatric settings

- Infection control in childcare, preschool, and school settings

This Collection supports and amplifies research related to SDG 3: Good Health and Well-being.

All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.

BMC Infectious Diseases invites submissions for a Collection on Tuberculosis immunology and infection.

Tuberculosis (TB) remains a global health challenge, with millions affected by Mycobacterium tuberculosis each year. The interplay between the bacterium and the host's immune response is complex, involving various cellular and molecular mechanisms that determine the outcome of infection. Understanding the immunological aspects of TB is crucial for developing effective diagnostics, therapeutics, and vaccines. This Collection aims to explore the latest research on TB immunology, pathogenesis, and infection dynamics, shedding light on both latent and active TB states.

The significance of this research lies in its potential to inform public health strategies and interventions. Recent advances in immunological research and vaccine development have demonstrated promising avenues for tackling TB, including novel biomarkers for diagnosis and innovative vaccine candidates. Furthermore, the integration of genomic and proteomic technologies has provided deeper insights into the host-pathogen interactions, paving the way for more effective treatments and preventive measures. Continued focus on TB immunology will be vital in the global fight against this disease.

As research progresses, we anticipate breakthroughs that could transform TB management, including personalized vaccine strategies and targeted immunotherapies. The continued exploration of the immune response to TB may also yield critical insights into preventing reactivation of latent infections, ultimately contributing to the goal of TB eradication.

- Immune response to Mycobacterium tuberculosis

- Pathogenesis of latent and active TB

- Advances in TB vaccine development

- Novel diagnostic approaches for TB

This Collection supports and amplifies research related to SDG 3: Good Health and Well-being.

All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.